Cargando…

Modulation of Intestinal Epithelial Permeability by Plasma from Patients with Crohn’s Disease in a Three-dimensional Cell Culture Model

Intestinal epithelial barrier is affected by multiple factors, such as tumour necrosis factor-α (TNF-α). Plasma concentration of TNF-α is higher in patients with Crohn’s disease (CD) than healthy controls (HC) and correlates positively with disease activity. This study aimed to determine the effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Pan, Elamin, Elhaseen, Elizalde, Montserrat, Bours, Paul P. H. A., Pierik, Marieke J., Masclee, Ad A. M., Jonkers, Daisy M. A. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375954/ https://www.ncbi.nlm.nih.gov/pubmed/30765731 http://dx.doi.org/10.1038/s41598-018-38322-8

Ejemplares similares

Corticosteroid enhances epithelial barrier function in intestinal organoids derived from patients with Crohn’s disease
por: Xu, Pan, et al.
Publicado: (2021)

Fatty Acid Ethyl Esters Induce Intestinal Epithelial Barrier Dysfunction via a Reactive Oxygen Species-Dependent Mechanism in a Three-Dimensional Cell Culture Model
por: Elamin, Elhaseen, et al.
Publicado: (2013)

Effects of Ethanol and Acetaldehyde on Tight Junction Integrity: In Vitro Study in a Three Dimensional Intestinal Epithelial Cell Culture Model
por: Elamin, Elhaseen, et al.
Publicado: (2012)

The Intestinal Barrier in Irritable Bowel Syndrome: Subtype-Specific Effects of the Systemic Compartment in an In Vitro Model
por: Ludidi, Samefko, et al.
Publicado: (2015)

Ethanol Impairs Intestinal Barrier Function in Humans through Mitogen Activated Protein Kinase Signaling: A Combined In Vivo and In Vitro Approach
por: Elamin, Elhaseen, et al.
Publicado: (2014)

Fecal Microbial Composition of Ulcerative Colitis and Crohn’s Disease Patients in Remission and Subsequent Exacerbation
por: Wills, Edgar S., et al.
Publicado: (2014)

The fecal microbiota as a biomarker for disease activity in Crohn’s disease
por: Tedjo, Danyta. I., et al.
Publicado: (2016)

Intestinal barrier function is maintained with aging – a comprehensive study in healthy subjects and irritable bowel syndrome patients
por: Wilms, Ellen, et al.
Publicado: (2020)

Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta‐analysis
por: De Munck, Toon J. I., et al.
Publicado: (2020)

The Impact of Pectin Supplementation on Intestinal Barrier Function in Healthy Young Adults and Healthy Elderly
por: Wilms, Ellen, et al.
Publicado: (2019)

The reproducibility of skeletal muscle signal intensity on routine magnetic resonance imaging in Crohn's disease
por: Spooren, Corinne E.G.M., et al.
Publicado: (2020)

Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn’s Disease
por: Galazzo, Gianluca, et al.
Publicado: (2019)

The Effect of Sampling and Storage on the Fecal Microbiota Composition in Healthy and Diseased Subjects
por: Tedjo, Danyta I., et al.
Publicado: (2015)

Disease Activity Patterns of Crohn’s Disease in the First Ten Years After Diagnosis in the Population-based IBD South Limburg Cohort
por: Wintjens, Dion, et al.
Publicado: (2020)

Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn’s Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature
por: Smeets, Fabiënne G M, et al.
Publicado: (2019)

Higher Prevalence of Bacteroides fragilis in Crohn’s Disease Exacerbations and Strain-Dependent Increase of Epithelial Resistance
por: Becker, Heike E. F., et al.
Publicado: (2021)

Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial
por: Janssen, Laura, et al.
Publicado: (2021)

High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score
por: Bodelier, Alexander G. L., et al.
Publicado: (2016)

Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn’s Disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2021)

The Intestinal Fate of Citrus Flavanones and Their Effects on Gastrointestinal Health
por: Stevens, Yala, et al.
Publicado: (2019)

Inter-kingdom relationships in Crohn’s disease explored using a multi-omics approach
por: Frau, Alessandra, et al.
Publicado: (2021)

In vitro metabolic capacity of carbohydrate degradation by intestinal microbiota of adults and pre-frail elderly
por: An, Ran, et al.
Publicado: (2021)

The effect of olive leaf extract on cardiovascular health markers: a randomized placebo-controlled clinical trial
por: Stevens, Yala, et al.
Publicado: (2020)

Gut Microbiota and Intestinal Trans-Epithelial Permeability
por: Allam-Ndoul, Bénédicte, et al.
Publicado: (2020)

Exploration of the Esophageal Mucosal Barrier in Non-Erosive Reflux Disease
por: Rinsma, Nicolaas F., et al.
Publicado: (2017)

Assessing intestinal permeability in Crohn’s disease patients using orally administered (52)Cr-EDTA
por: von Martels, Julius Z. H., et al.
Publicado: (2019)

Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5
por: Wang, Mo, et al.
Publicado: (2021)

Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2022)

Plasma Metabolic and Lipidomic Fingerprinting of Individuals with Increased Intestinal Permeability
por: Shah, Rohan M., et al.
Publicado: (2022)

The Intake of Dicarbonyls and Advanced Glycation Endproducts as Part of the Habitual Diet Is Not Associated with Intestinal Inflammation in Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients
por: de Graaf, Marlijne C. G., et al.
Publicado: (2022)

A profile of volatile organic compounds in exhaled air as a potential non-invasive biomarker for liver cirrhosis
por: Pijls, Kirsten E., et al.
Publicado: (2016)

Real-time Measurement of Epithelial Barrier Permeability in Human Intestinal Organoids
por: Hill, David R., et al.
Publicado: (2017)

Palmitic Acid Affects Intestinal Epithelial Barrier Integrity and Permeability In Vitro
por: Gori, Manuele, et al.
Publicado: (2020)

PGI(2) Inhibits Intestinal Epithelial Permeability and Apoptosis to Alleviate Colitis
por: Pochard, Camille, et al.
Publicado: (2021)

Scoping review on health-related physical fitness in patients with inflammatory bowel disease: Assessment, interventions, and future directions
por: Demers, Karlijn, et al.
Publicado: (2023)

Severe COVID-19 in inflammatory bowel disease patients in a population-based setting
por: Creemers, Rob H., et al.
Publicado: (2021)

Systematic Review: Contribution of the Gut Microbiome to the Volatile Metabolic Fingerprint of Colorectal Neoplasia
por: van Vorstenbosch, Robert, et al.
Publicado: (2022)

Crohn’s Disease Pathobiont Adherent-Invasive E coli Disrupts Epithelial Mitochondrial Networks With Implications for Gut Permeability
por: Mancini, Nicole L., et al.
Publicado: (2020)

BVES Is Required for Maintenance of Colonic Epithelial Integrity in Experimental Colitis by Modifying Intestinal Permeability
por: Choksi, Yash A., et al.
Publicado: (2018)

Metagenomic Profiling of Fecal-Derived Bacterial Membrane Vesicles in Crohn’s Disease Patients
por: Kameli, Nader, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iqtrrul2fvsqhkbpj74h118c02